Valuation Emcure Pharmaceuticals Limited

Stocks

End-of-day quote NSE India S.E. 30/10/2026			5-day change	1st Jan Change
1,871.80 ^INR	+0.36%		+5.73%	+37.18%

10-02	Emcure Pharmaceuticals Limited Receives Income-Tax Department Orders Imposing Aggregate Penalty of INR 577.396732 Million	CI
09-23	Emcure Pharmaceuticals Limited Approves Final Dividend for the Financial Year Ended March 31, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: March	2025	2026	2027	2028	2029
Market Cap ¹	203,202	302,490	355,043	-	-
Change	-	48.86%	17.37%	-	-
Enterprise Value (EV) ¹	208,106	306,160	361,427	351,765	339,545
Change	-	47.12%	18.05%	-2.67%	-3.47%
P/E	29.4x	32.7x	29.8x	24.1x	20.1x
PBR	4.57x	-	5.83x	4.74x	3.89x
PEG	-	1x	1x	1x	1x
Capitalization / Revenue	2.57x	3.29x	3.35x	2.96x	2.65x
EV / Revenue	2.64x	3.33x	3.41x	2.94x	2.53x
EV / EBITDA	14.2x	17.1x	16.7x	13.8x	11.7x
EV / EBIT	19.2x	22.3x	21.2x	17.1x	14.1x
EV / FCF	33x	52.5x	36.5x	29.7x	22.8x
FCF Yield	3.03%	1.9%	2.74%	3.36%	4.39%
Dividend per Share ²	3	3.6	4.007	4.728	5.773
Rate of return	0.28%	0.23%	0.21%	0.25%	0.31%
EPS ²	36.43	48.77	62.72	77.66	92.93
Distribution rate	8.23%	7.38%	6.39%	6.09%	6.21%
Net sales ¹	78,960	92,035	106,051	119,824	133,996
EBITDA ¹	14,689	17,890	21,618	25,428	29,101
EBIT ¹	10,847	13,740	17,017	20,571	24,113
Net income ¹	6,813	9,244	11,895	14,608	17,577
Net Debt ¹	4,904	3,670	6,384	-3,278	-15,498
Reference price ²	1,072.40	1,595.50	1,871.80	1,871.80	1,871.80
Nbr of stocks (in thousands)	189,483	189,590	189,680	-	-
Announcement Date	22/05/25	05/05/26	-	-	-

¹INR in Million²INR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
EMCURE PHARMACEUTICALS LIMITED	29.84x	3.41x	16.72x	0.21%	3.74B
ELI LILLY AND COMPANY	41.54x	14.06x	31.11x	0.48%	1,263B
JOHNSON & JOHNSON	39.99x	6.71x	18.89x	1.95%	658B
ABBVIE INC.	36.71x	8.6x	17.71x	2.33%	521B
ROCHE HOLDING AG	21.74x	5.27x	13.12x	2.48%	391B
MERCK & CO., INC.	109.15x	6.06x	25.73x	2.28%	369B
NOVARTIS AG	23.19x	5.95x	14.36x	2.69%	307B
ASTRAZENECA PLC	24.47x	4.9x	13.63x	1.77%	290B
AMGEN INC.	29.55x	7.53x	13.48x	2.16%	252B
GILEAD SCIENCES, INC.	-41.18x	7.46x	46.76x	1.93%	212B
Average	31.50x	7.00x	21.15x	1.83%	426.57B
Weighted average by Cap.	37.44x	8.83x	22.80x	1.69%